Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1040 dias atrás
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

Etiquetas: HOTH
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 784 dias atrás
Swiss Market Pares Early Gains, Settles Flat

Swiss Market Pares Early Gains, Settles Flat

Save for a brief while during the closing minutes, Switzerland's SMI index stayed positive on Monday, but still ended the session with just a slender gain as several stocks pared early gains due to a lack of support at higher levels.
RTTNews | 4 h 15 min atrás
European Stocks Close Higher As Investors Asses Economic Data, Recent Earnings

European Stocks Close Higher As Investors Asses Economic Data, Recent Earnings

European markets closed mostly higher on Monday, led by gains in the banking and automobile sectors. Investors assessed U.S.-China trade discussions, recent earnings updates, and digested the latest batch of regional economic data, in addition to awaiting the Bank of England's monetary policy announcement due this week.
RTTNews | 4 h 46 min atrás
U.S. Manufacturing Index Unexpectedly Edges Lower In October

U.S. Manufacturing Index Unexpectedly Edges Lower In October

Manufacturing activity in the U.S. unexpectedly contracted at a slightly faster rate in the month of October, according to a report released by the Institute for Supply Management on Monday. The ISM said its manufacturing PMI slipped to 48.7 in October after edging up to 49.1 in September, with a reading below 50 indicating contraction. Economists had expected the index to inch up to 49.5.
RTTNews | 7 h 1 min atrás
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Canadian shares are likely to open higher Monday morning, with firm metal prices expected to trigger buying in the materials sector. The focus will be on the developments on the trade front and corporate earnings announcements.
RTTNews | 9 h 2 min atrás